Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
Jinfo Article
23rd January 2018
By Scott Vine
Abstract
The third part of Jinfo's product review of DrugPatentWatch, a database which provides actionable business intelligence on small-molecule drugs, we highlight the search interface and functionality, provide a detailed look at the content and sources available in the product, typical use-cases as well as outputs and alerts available and its administrative capabilities.
Note: Full review (PDF) at /go/sub/report/2934
Content Access
Access to Jinfo Content and Community is available through a Jinfo Subscription.
Does your organisation have a Jinfo Subscription?
"Not yet"
Access to this article is available through a Jinfo Subscription, which will help your organisation:
- Save time and money
- Re-invent information services
- Define, measure and communicate information value.
"Don't know"
Contact us to find out if your organisation already has a Jinfo Subscription.
Or use the 'Text Chat' button at the bottom-right of this page for immediate assistance.
- Article title: Product review of DrugPatentWatch (technology - search & user interface; outputs & alerts; administration)
- Link to this page
- View printable version
- Product review of DrugPatentWatch (value - help & training; competitors; development; pricing)
Wednesday, 24th January 2018 - Product review of DrugPatentWatch (sources - content & coverage)
Monday, 22nd January 2018 - Product review of DrugPatentWatch (key advantages; introduction; contact details)
Friday, 19th January 2018
- Driving pharma research with AdisInsight
Monday, 20th March 2017
- Product review of DrugPatentWatch
Friday, 19th January 2018
Vendor adoption of AI
Community session
23rd May 2024
Mainstream GenAI, emerging vendors and your offshore resourcing strategy
Blog posting
9th May 2024
May 2024 Update
YouTube video
9th May 2024
- Jinfo Community session (TBC) (Community) 16th July 2024
- Jinfo Community session (TBC) (Community) 18th June 2024
- Vendor adoption of AI (Community) 23rd May 2024